Polymyalgia rheumatica is an inflammatory disorder characterised by bilateral pain and stiffness in the shoulder and hip regions, typically affecting individuals over 50 years of age. It is clinically significant as it can lead to substantial disability if untreated and is often associated with giant cell arteritis, increasing the risk of serious complications such as vision loss. Early recognition and corticosteroid treatment are crucial for effective management and improving patient outcomes.